These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 10122036)

  • 1. Issues in formulary management: therapeutic interchange. Establishing guidelines: roundtable discussion, Part 1.
    Mahoney C; Cichon M; Cromer M; DeGiulio H; Renshaw B; Rodriguez FA; Wert D
    Hosp Formul; 1992 Oct; 27 Suppl 2():4-8. PubMed ID: 10122036
    [No Abstract]   [Full Text] [Related]  

  • 2. Issues in formulary management: therapeutic interchange. Communicating a policy: roundtable discussion, Part 2.
    Cichon M; Mahoney C; Renshaw B; Cromer M; Rodriguez FA; DeGiulio H; Wert D
    Hosp Formul; 1992 Oct; 27 Suppl 2():9-12. PubMed ID: 10122037
    [No Abstract]   [Full Text] [Related]  

  • 3. Issues in formulary management: therapeutic interchange. The value, cost, and quality of therapeutic interchange.
    Mahoney CD
    Hosp Formul; 1992 Oct; 27 Suppl 2():2-3. PubMed ID: 10122035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Legal and medical issues in therapeutic interchange: implications for pharmacists, physicians, and P & T committees.
    Plumeri PA; Crane VS
    Hosp Formul; 1992 Oct; 27(10):1040-2, 1047-8. PubMed ID: 10121419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multidisciplinary process to determine, communicate, and manage an antibiotic formulary.
    Cook AA; Sanchez ML
    Hosp Pharm; 1992 Oct; 27(10):867-9, 872-4, 882. PubMed ID: 10121423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guidelines for therapeutic interchange-2004.
    Gray T; Bertch K; Galt K; Gonyeau M; Karpiuk E; Oyen L; Sudekum MJ; Vermeulen LC;
    Pharmacotherapy; 2005 Nov; 25(11):1666-80. PubMed ID: 16232030
    [No Abstract]   [Full Text] [Related]  

  • 7. ASHP guidelines on formulary system management.
    Am J Hosp Pharm; 1992 Mar; 49(3):648-52. PubMed ID: 1598948
    [No Abstract]   [Full Text] [Related]  

  • 8. Guidelines on the operation of the pharmacy and therapeutics committee and formulary.
    Linkewich JA; Prevoznik SJ
    Hosp Pharm; 1979 Jan; 14(1):7-10, 13, 16-9 passim. PubMed ID: 10240149
    [No Abstract]   [Full Text] [Related]  

  • 9. Rational selection of H2-receptor antagonists for the hospital formulary. Roundtable discussion.
    Keeffe EB; Harper JM; LeMay A; Sherrin TP; Siepler JK
    Hosp Formul; 1991 Nov; 26 Suppl D():13-9. PubMed ID: 10136560
    [No Abstract]   [Full Text] [Related]  

  • 10. Formulary management: antibiotics and therapeutic interchange.
    Massoomi F
    Pharm Pract Manag Q; 1996 Oct; 16(3):11-8. PubMed ID: 10166231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Editors' roundtable: current formulas for P & T Committee success. (Part 2).
    Lipman AG; Neu HC; Singh BN; Weintraub M
    Hosp Formul; 1987 Apr; 22(4):373-82. PubMed ID: 10281367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Achieving rational therapeutics through consensus-based protocols and follow-up.
    Quintiliani R; Gousse GC; Chow MS
    Hosp Formul; 1990 Mar; 25(3):283-4, 289-94. PubMed ID: 10103836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experience with a two-tiered therapeutic interchange policy.
    Rich DS
    Am J Hosp Pharm; 1989 Sep; 46(9):1792-8. PubMed ID: 2572167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Key inventory to formulary to cut drug costs.
    Schmieding JL; Sita MJ
    Hospitals; 1980 Sep; 54(17):78-81. PubMed ID: 7399457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacoeconomic series: Part 3. Applying pharmacoeconomic and quality-of-life measures to the formulary management process.
    Skaer TL
    Hosp Formul; 1993 Jun; 28(6):577-84. PubMed ID: 10126586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effective decision-making in a changing healthcare environment: a P & T Committee interview.
    Zoloth A; Yon JL; Woolf R
    Hosp Formul; 1989 Feb; 24(2):85-7, 90, 93 passim. PubMed ID: 10291815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formulary management to reduce cost: P & T committee strategies.
    Roberts MJ; Summerfield MR
    Hosp Formul; 1986 Apr; 21(4):481-3, 488-92. PubMed ID: 10276289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. P & T Committee response to evolving technologies: preparing for the launch of high-tech, high-cost products. Roundtable discussion.
    Seltzer JL; Wordell CJ; Nash D; Johnson NE; Gottlieb JE
    Hosp Formul; 1992 Apr; 27(4):379-80, 386-92. PubMed ID: 10117768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P & T Committee roundtable discussion: Eastern region Pt. II.
    Fine DJ; Guild RT; Kleinmann K; Kupersmith J
    Hosp Formul; 1984 Jul; 19(7):561-4, 568-70. PubMed ID: 10267389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formulary management at a tertiary care teaching hospital.
    Mutnick AH; Ross MB
    Pharm Pract Manag Q; 1997 Apr; 17(1):63-87. PubMed ID: 10166245
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.